Evidence of Catecholamine Mediation in the "aberrant" Behaviour Induced by Lysergic Acid Diethylamide (LSD) in the Rat

Overview

Journal Experientia

Specialty Science

Date 1968 Jul 15

PMID 4387561

Citations 20

Authors

A K Dixon

Affiliations

Soon will be listed here.

Citing Articles

Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.

Winter J Psychopharmacology (Berl). 2008; 203(2):251-63.

PMID: 18979087 DOI: 10.1007/s00213-008-1356-8.

LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors.

Watts V, Lawler C, Fox D, Neve K, Nichols D, Mailman R Psychopharmacology (Berl). 1995; 118(4):401-9.

PMID: 7568626 DOI: 10.1007/BF02245940.

The effects of naloxone, chlorpromazine, and haloperidol pretreatment on levallorphan-induced disruption of rats' operant behaviour.

Wray S, Cowan A Psychopharmacologia. 1971; 22(3):261-70.

PMID: 5132008 DOI: 10.1007/BF00401788.

The behavioural effects of levallorphan, cyprenorphine (M285) and amphetamine on repeated Y-maze performance in rats.

Wray S, Cowan A Psychopharmacologia. 1971; 21(3):257-67.

PMID: 5095415 DOI: 10.1007/BF00403864.

A correlative evaluation of cyclazocine, LSD and naloxone on continuous discriminated avoidance in rats.

Wray S Psychopharmacologia. 1972; 26(1):29-43.

PMID: 5051460 DOI: 10.1007/BF00421916.

References

VOTAVA Z, Glisson S, Himwich H . Behavioral reaction of rats pretreated with reserpine to LSD-25. Int J Neuropharmacol. 1967; 6(6):543-7. DOI: 10.1016/0028-3908(67)90053-6. View

STJAERNE L . STUDIES OF CATECHOLAMINE UPTAKE STORAGE AND RELEASE MECHANISMS. Acta Physiol Scand Suppl. 1964; :SUPPL 228:1-97. View

MUSACCHIO J, Kopin I, Snyder S . EFFECTS OF DISULFIRAM ON TISSUE NOREPINEPHRINE CONTENT AND SUBCELLULAR DISTRIBUTION OF DOPAMINE, TYRAMINE AND THEIR BETA-HYDROXYLATED METABOLITES. Life Sci (1962). 1964; 3:769-75. DOI: 10.1016/0024-3205(64)90032-3. View

Horita A, DILLE J . Pyretogenic effect of lysergic acid diethylamide. Science. 1954; 120(3131):1100-1. DOI: 10.1126/science.120.3131.1100. View

Glowinski J, Axelrod J . INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS. Nature. 1964; 204:1318-9. DOI: 10.1038/2041318a0. View

Gaddum J, HAMEED K, HATHWAY D, STEPHENS F . Quantitative studies of antagonists for 5-hydroxytryptamine. Q J Exp Physiol Cogn Med Sci. 1955; 40(1):49-74. DOI: 10.1113/expphysiol.1955.sp001097. View

CERLETTI A, ROTHLIN E . Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives. Nature. 1955; 176(4486):785-6. DOI: 10.1038/176785a0. View

Goldstein M, ANAGNOSTE B, Lauber E, MCKEREGHAM M . INHIBITION OF DOPAMINE-BETA-HYDROXYLASE BY DISULFIRAM. Life Sci (1962). 1964; 3:763-7. DOI: 10.1016/0024-3205(64)90031-1. View

WOOLLEY D, Shaw E . A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS. Proc Natl Acad Sci U S A. 1954; 40(4):228-31. PMC: 527980. DOI: 10.1073/pnas.40.4.228. View

10.

Horita A, GOGERTY J . The pyretogenic effect of 5-hydroxytryptophan and its comparison with that of ISD. J Pharmacol Exp Ther. 1958; 122(2):195-200. View

11.

DOEPFNER W . Biochemical observations on LSD-25 and Deseril. Experientia. 1962; 18:256-7. DOI: 10.1007/BF02148217. View

12.

Goldstein M . Inhibition of norepinephrine biosynthesis at the dopamine-beta-hydroxylation stage. Pharmacol Rev. 1966; 18(1):77-82. View

13.

Costa E, Gessa G, Hirsch C, Kuntzman R, Brodie B . On current status of serotonin as a brain neurohormone and in action of reserpinelike drugs. Ann N Y Acad Sci. 1962; 96:118-33. DOI: 10.1111/j.1749-6632.1962.tb50107.x. View

14.

SHARMAN D . A discussion of the modes of action of drugs which increase the concentration of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) in the striatum of the mouse. Br J Pharmacol Chemother. 1967; 30(3):620-6. PMC: 1557317. DOI: 10.1111/j.1476-5381.1967.tb02168.x. View

15.

ROSECRANS J, Lovell R, Freedman D . Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine. Biochem Pharmacol. 1967; 16(10):2011-21. DOI: 10.1016/0006-2952(67)90313-9. View

16.

KOE B, Weissman A . p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther. 1966; 154(3):499-516. View

17.

ERSPAMER V . Pharmacological studies on enteramine (5-hydroxytryptamine) IX. Influence of sympathomimetic and sympatholytic drugs on the physiological and pharmacological actions of enteramine. Arch Int Pharmacodyn Ther. 1953; 93(3-4):293-316. View

18.

WOOLLEY D, Shaw E . Some neurophysiological aspects of serotonin. Br Med J. 1954; 2(4880):122-6. PMC: 2079253. DOI: 10.1136/bmj.2.4880.122. View

19.

Spector S, SJOERDSMA A, UDENFRIEND S . BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. J Pharmacol Exp Ther. 1965; 147:86-95. View

20.

SHARMAN D . Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Br J Pharmacol Chemother. 1966; 28(2):153-63. PMC: 1510867. DOI: 10.1111/j.1476-5381.1966.tb01881.x. View